Factors Associated With Public Trust in Pharmaceutical Manufacturers.
作者信息
Singh Yashaswini, Eisenberg Matthew D, Sood Neeraj
机构信息
Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
Sol Price School of Public Policy, University of Southern California, Los Angeles.
出版信息
JAMA Netw Open. 2023 Mar 1;6(3):e233002. doi: 10.1001/jamanetworkopen.2023.3002.
Abstract
摘要
相似文献
1
Factors Associated With Public Trust in Pharmaceutical Manufacturers.与公众对制药企业信任相关的因素。
JAMA Netw Open. 2023 Mar 1;6(3):e233002. doi: 10.1001/jamanetworkopen.2023.3002.
2
Public's distrust of medicines needs urgent action, says academy.该学会表示，公众对药品的不信任需要立即采取行动。
BMJ. 2017 Jun 19;357:j2974. doi: 10.1136/bmj.j2974.
3
[Early achievements of the Danish pharmaceutical industry--8. Lundbeck].[丹麦制药行业的早期成就——8. 灵北公司]
Theriaca. 2016(43):9-61.
4
[Medical opinion leaders conflict of interests: effects of disclosures on the trust of the public and general practitioners].[医学意见领袖的利益冲突：披露对公众和全科医生信任的影响]
Rev Epidemiol Sante Publique. 2011 Aug;59(4):233-42. doi: 10.1016/j.respe.2010.12.011. Epub 2011 Jul 14.
5
Public perceptions of the association between drug effectiveness and drug novelty in France during the COVID-19 pandemic.公众对 COVID-19 大流行期间法国药物有效性和新颖性之间关联的看法。
Therapie. 2022 Nov-Dec;77(6):693-701. doi: 10.1016/j.therap.2022.05.001. Epub 2022 May 7.
6
Ensuring public trust.确保公众信任。
Biol Psychiatry. 2004 Oct 15;56(8):539. doi: 10.1016/j.biopsych.2004.09.002.
7
Braving a faceless new world? Conceptualizing trust in the pharmaceutical industry and its products.勇敢面对一个陌生的新世界？概念化对制药行业及其产品的信任。
Health (London). 2012 Jan;16(1):57-75. doi: 10.1177/1363459309360783. Epub 2010 Dec 15.
8
Restoring confidence in the pharmaceutical industry.恢复对制药行业的信心。
JAMA. 2013 Feb 13;309(6):607-9. doi: 10.1001/jama.2013.58.
9
Coxibs, science, and the public trust.环氧化酶-2抑制剂、科学与公众信任。
Arch Intern Med. 2005 Jan 24;165(2):158-60. doi: 10.1001/archinte.165.2.158.
10
Health care and the pharmaceutical industry.医疗保健与制药行业。
J Parenter Sci Technol. 1993 Sep-Oct;47(5):191.
引用本文的文献
1
Evolving demographics of eligible patient population can impact enrollment of a biomarker clinical study.符合条件的患者群体不断变化的人口统计学特征可能会影响生物标志物临床研究的入组情况。
PLoS One. 2025 May 9;20(5):e0323187. doi: 10.1371/journal.pone.0323187. eCollection 2025.
2
Embracing Medicines Development as a Profession.将药物研发视为一种职业。
Pharmaceut Med. 2025 Mar 13. doi: 10.1007/s40290-025-00556-z.
3
Promoting Diversity through an Understanding of Barriers and Drivers for Inclusive Clinical Trials.通过理解包容性临床试验的障碍和驱动因素促进多样性
Ther Innov Regul Sci. 2025 May;59(3):596-605. doi: 10.1007/s43441-025-00751-9. Epub 2025 Feb 26.
4
Determinants of COVID-19 Vaccine Hesitancy: A Cross-Sectional Study in Three Communities in the United States and Lebanon.新冠疫苗犹豫的决定因素：在美国和黎巴嫩三个社区开展的一项横断面研究
Microorganisms. 2024 Jun 14;12(6):1200. doi: 10.3390/microorganisms12061200.
本文引用的文献
1
Association of Direct-to-Consumer Advertising of Prescription Drugs With Consumer Health-Related Intentions and Beliefs Among Individuals at Risk of Cardiovascular Disease.直接面向消费者的处方药广告与心血管疾病风险人群的消费者健康相关意图和信念的关联。
JAMA Health Forum. 2022 Aug 5;3(8):e222570. doi: 10.1001/jamahealthforum.2022.2570.
2
Patient distrust in pharmaceutical companies: an explanation for women under-representation in respiratory clinical trials?患者对制药公司的不信任：呼吸临床试验中女性代表性不足的一个解释？
BMC Med Ethics. 2020 Aug 13;21(1):72. doi: 10.1186/s12910-020-00509-y.
3
Medication Adherence: Truth and Consequences.药物依从性：真相与后果
Am J Med Sci. 2016 Apr;351(4):387-99. doi: 10.1016/j.amjms.2016.01.010.
Zotero 插件